Sanofi (SNY)
Symbol Info
Listed Symbol SNY
Name Sanofi
Share Info
Annual Info
Latest Fiscal Dividend Per Share $1,83
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $39 603 328 765
Latest Fiscal EPS $1.97
Price Info
21 Day Moving Average $45,6352
21 Day EMA $45,302820
50 Day Moving Average $44,2312
50 Day EMA $44,489840
200 Day EMA $42,756860
200 Day Moving Average 42,269530
52 Week High $47.11
52 Week Low $40,00
52 Week Change $8.160900
Alpha 0.000105
Beta 0.6009
Standard Deviation 0.047855
R2 0.185943
Periods 60
Share Information
10 Day Average Volume 761 513
20 Day Average Volume 1 626 631
30 Day Average Volume 1 647 577
50 Day Average Volume 1 424 287
Outstanding Shares 2 504 267 038
Float Shares 2 504 267 038
Percent Float 100,00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 705
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 38 977 130
Institute Holdings Percent 9,400000
Institute Sold Previous 3 Months 15 662 999
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $1,2199974
7 Day Percent Change 2,71%
21 Day Price Change $-0,0900002
21 Day Percent Change -0,19%
30 Day Price Change $1,7599983
30 Day Percent Change 3,96%
Month To Date Price Change $-0,16
Month To Date Percent -0,35%
90 Day Price Change $4,219997
90 Day Percent Change 10,06%
Quarter To Date $-0,160004
Quarter To Date Percent -0,35%
180 Day Price Change $6,499016
180 Day Percent Change 16,38%
200 Day Price Change $3,627644
200 Day Percent Change 8,53%
Year To Date $4,482334
Year To Date Percent 10,75%
Profile
Description Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just under 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of sales.
Details
Issue Type CS
Market Cap $115 622 009 144
Sec Type DR
Auditor PricewaterhouseCoopers Audit
Total Shares Outstanding 2 504 267 038
CEO Olivier Brandicourt
Employees 100 000
Last Audit UQ
Classification
CIK 0001121404
Industry Drug Manufacturers
Sector Healthcare
NAICS
Info
Address 54, Rue La Boétie
Paris, 75008
Website http://www.sanofi.com
Facisimile +33 153774303
Telephone +33 153774000
Email IR@sanofi.com
Key Ratios
Profitability
EBIT Margin 10,30
EBITDA Margin 27,4
Pre-Tax Profit Margin 15,2
Profit Margin Cont 5,05
Gross Margin 68,60
Profit Margin TOT 5,02
Income Statements
Revenue $29 391 764 305
Revenue Per Share $10,3887
Revenue 3 Years $-3,91
Revenue 5 Years $-1,89
Valuation Measures
PE Ratio 27,30
Enterprise Value $138 360 443 816
Price To Sales 4,444265
Price To Free Cash -57,2
PE High Last 5 Years 30,2
Price To Book 1,8
Price To Cash Flow 14,7
PE Low Last 5 Years 9,4
Price To Tangible Book -13,6
Financial Strength
Total Debt To Equity 0,5
Int Coverage 9,1
Current Ratio 1,3
Leverage Ratio 1,9
Quick Ratio 0,7
Long Term Debt To Capital 0,28
Assets
Receivables Turnover 3,2
Invoice Turnover 1,80
Assets Turnover 0,20
Management Effectiveness
Return Assets 3,16
Return On Equity 6,28
Return On Capital 4,61
Dividends
Dividend 3 Years $2,65
Dividend 5 Years $-0,9
Ex Dividend Date 2019-05-07 00:00:00.0
Dividend Rate $1,72
Dividend Yield 3,73%
Payment Type Cash
Dernières Valeurs Consultées
NASDAQ
SNY
Sanofi
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20191020 06:02:48